🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I agree. It is ideal to avoid harming animals. The question is whether this will affect the speed of developing cancer drugs. So far, I have not heard of a discovery that is a reliable or robust non-animal method that allows for human clinical trials. Trying but very hard.

🔥 (1/2) Trastuzumab Deruxtexan (T-DXd) makes a breakthrough also in early HER2+ breast cancer❗️ 👉 THP and T-DXd are non cross-resistant therapies, sequencing is a winning strategy 👉 confirm DB05 will be positive Open questions 👇👇👇👇👇 astrazeneca.com/media-centre/p…

How do we improve outcomes and access to novel therapies for patients with CNS metastases 🧠 in #breastcancer❓ What about brain metastases 🧠screening❓ A critical topic at 3rd Nis Oncology Conference #NOK2025 OncoAlert #BreastCancer #BrainMetastases #Oncology

This seems like common sense to me in HER2+ and TNBC MBC. Given the tools we have in 2025, why would wait until brain metastases are so large they cause symptoms to start looking.

Online Now: Brain metastasis: From etiology to ecotypes dlvr.it/TKjkbd

1/5 People living with sickle-cell disease (SCD) face ↑ cancer risk, including #RenalMedullaryCarcinoma. Our latest Immunity study suggests a culprit is the reshaping CD8⁺ T cell chromatin by SCD 👉authors.elsevier.com/sd/article/S10… #MsaouelLab

Fantastic Cancer Cell paper by Linghua Wang, MD, PhD MD Anderson Cancer Center revealing new biology in cancer-associated fibroblasts. cell.com/cancer-cell/fu…

You heard it first at #ESMOBreast25: Dr. Hortobagyi shared that the MONALEESA-2 trial was conceived on a napkin at a famous French restaurant. A powerful reminder that networking and informal conversations at meetings can spark paradigm-shifting ideas ESMO - Eur. Oncology

Tour de force by MD Anderson Cancer Center ESMO - Eur. Oncology breast cancer 2025 award winner Dr. Hortobagyi on the progress in HR+ breast cancer! Amazing career and impact! #bcsm

Excited to share our recent nature paper! nature.com/articles/s4158… Tremendous collaborative effort from UChicagoCancerCenter The University of Chicago University of Chicago Radiation Oncology Ralph Weichselbaum

IFN-γ orchestrates anti-tumor responses against leptomeningeal metastasis through an unexpected series of cell–cell interactions: cDC maturation and NK cell activity nature Adrienne Boire nature.com/articles/s4158… nature.com/articles/d4158…

Thanks to a generous $150 million gift from Kinder Foundation, we announce the launch of Kinder Children’s Cancer Center. This joint venture of UT MD Anderson and Texas Children's has a single mission: to #EndChildhoodCancer. brnw.ch/21wSEOo #UTMDAnderson_TexasChildrens

We MD Anderson Cancer Center are grateful to Kinder Foundation and Rich and Nancy Kinder for their gift to bring Kinder Children’s Cancer Center to life. Proud to work with Debbie Sukin and Texas Children's to build the preeminent children’s cancer center. #UTMDAnderson_TexasChildrens

Important publicly available resource from Tirosh Lab Weizmann Institute in Nature Cancer The Curated Cancer Cell Atlas provides a comprehensive characterization of tumors at single-cell resolution nature.com/articles/s4301… 124 single cell datasets across 40 cancers, >2800 samples.

Thanks ESMO - Eur. Oncology for including IBC in the #esmobreast2025 line up. Great brainstorming with this group and strong message: guideline concordant care for all IBC, use the Susan G. Komen IBC tools at diagnosis, don’t de-escalate off protocol! #bcsm #thinkibc

Thrilled to share that our manuscript, “Inhibition of MCL-1 and MEK overcomes MEK inhibitor resistance in TNBC and IBC is published in Molecular Cancer Therapeutics! Grateful to nick Adam Spangler MD Anderson Cancer Center @State of Texas for the funding . Dr. Mohd Mughees doi.org/10.1158/1535-7…

🦴Our Science Translational Medicine study discovered ACBP as a metabolic driver of #BONE #metastasis. 🔬 Blocking fatty acid oxidation or inducing ferroptosis shuts down bone metastasis in vivo. 📰 MD Anderson Cancer Center highlight: mdanderson.org/newsroom/resea… Albert Koong, MD PhD Giulio Draetta Carin Hagberg, MD

Please check out our paper published today in Nature that identifies CREM as a key checkpoint limiting CAR NK cell function.CRISPR knockout of CREM significantly enhanced anti-tumor activity, implicating a broader role in NK cell regulation. Huge congrats to @hindrafei and our

The new Huberman Lab episode is out: Improving Science & Restoring Trust in Public Health | Dr. Jay Bhattacharya (Jay Bhattacharya, MD, PhD) (0:00) Jay Bhattacharya (6:56) National Institutes of Health (NIH), Mission (9:12) Funding, Basic vs. Applied Research (18:22) Sponsors:

🔥New pub from the lab demonstrating that CREB-mediated cholesterol metabolism is a druggable cancer target downstream of #CAMKK2 in #CRPC. This work was led by the great Chenchu w/ big help from others including Wenyi Wang & Eberlin Lab. cell.com/cell-reports/f… 1/5